Sensors for Medicine and Science Raises $54.1 Million Series D Financing
Venture Capital Tuesday, November 1st, 2011GERMANTOWN, MD — (Marketwire) — 11/01/11 — (SMSI), a privately held medical device company focused on the development and commercialization of the first fully implantable, long-term (CGM) system for people with diabetes, announced today a $54.1 million Series D equity financing. The funding was led by new investor Delphi Ventures, with significant participation from existing investors New Enterprise Associates (NEA), HealthCare Ventures, Anthem Capital and Greenspring Associates.The Serie
